Business Description
Torii Pharmaceutical Co Ltd
ISIN : JP3635800000
Share Class Description:
TSE:4551: Ordinary SharesDescription
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 180.34 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.68 | |||||
| Beneish M-Score | -1.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.4 | |||||
| 3-Year EBITDA Growth Rate | 8 | |||||
| 3-Year EPS without NRI Growth Rate | -1.7 | |||||
| 3-Year FCF Growth Rate | 4.7 | |||||
| 3-Year Book Growth Rate | 1.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.31 | |||||
| 9-Day RSI | 49.02 | |||||
| 14-Day RSI | 45.74 | |||||
| 6-1 Month Momentum % | 9.59 | |||||
| 12-1 Month Momentum % | 18.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.05 | |||||
| Quick Ratio | 6.19 | |||||
| Cash Ratio | 3.52 | |||||
| Days Inventory | 127.99 | |||||
| Days Sales Outstanding | 164.48 | |||||
| Days Payable | 88.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.11 | |||||
| Dividend Payout Ratio | 0.86 | |||||
| 3-Year Dividend Growth Rate | 35.7 | |||||
| Forward Dividend Yield % | 3.11 | |||||
| 5-Year Yield-on-Cost % | 8.2 | |||||
| Shareholder Yield % | 3.37 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.37 | |||||
| Operating Margin % | 9.23 | |||||
| Net Margin % | 7.54 | |||||
| FCF Margin % | -6.11 | |||||
| ROE % | 3.47 | |||||
| ROA % | 3.12 | |||||
| ROIC % | 4.8 | |||||
| ROC (Joel Greenblatt) % | 17.57 | |||||
| ROCE % | 4.67 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 26.31 | |||||
| PE Ratio without NRI | 27.57 | |||||
| Shiller PE Ratio | 17.51 | |||||
| PS Ratio | 1.98 | |||||
| PB Ratio | 0.9 | |||||
| Price-to-Tangible-Book | 0.91 | |||||
| EV-to-EBIT | 11.55 | |||||
| EV-to-EBITDA | 11.55 | |||||
| EV-to-Revenue | 1.18 | |||||
| EV-to-FCF | -19.34 | |||||
| Price-to-Projected-FCF | 0.66 | |||||
| Price-to-Median-PS-Value | 1.28 | |||||
| Price-to-Graham-Number | 1.05 | |||||
| Price-to-Net-Current-Asset-Value | 1.45 | |||||
| Price-to-Net-Cash | 3.53 | |||||
| Earnings Yield (Greenblatt) % | 8.66 | |||||
| FCF Yield % | -3.08 | |||||
| Forward Rate of Return (Yacktman) % | -2.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Torii Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 54,637 | ||
| EPS (TTM) (円) | 146.511 | ||
| Beta | 0.46 | ||
| Volatility % | 19.8 | ||
| 14-Day RSI | 45.74 | ||
| 14-Day ATR (円) | 91.123823 | ||
| 20-Day SMA (円) | 3906 | ||
| 12-1 Month Momentum % | 18.17 | ||
| 52-Week Range (円) | 3275 - 4370 | ||
| Shares Outstanding (Mil) | 28.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Torii Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Torii Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Torii Pharmaceutical Co Ltd Frequently Asked Questions
What is Torii Pharmaceutical Co Ltd(TSE:4551)'s stock price today?
The current price of TSE:4551 is 円3855.00. The 52 week high of TSE:4551 is 円4370.00 and 52 week low is 円3275.00.
When is next earnings date of Torii Pharmaceutical Co Ltd(TSE:4551)?
The next earnings date of Torii Pharmaceutical Co Ltd(TSE:4551) is .
Does Torii Pharmaceutical Co Ltd(TSE:4551) pay dividends? If so, how much?
The Dividend Yield %  of Torii Pharmaceutical Co Ltd(TSE:4551) is 3.11% (As of Today), Highest Dividend Payout Ratio of Torii Pharmaceutical Co Ltd(TSE:4551) was 1.1. The lowest was 0.28. And the median was 0.44. The  Forward Dividend Yield % of Torii Pharmaceutical Co Ltd(TSE:4551) is 3.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers